CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 11 enrolled
Drug / intervention
Transcranial Direct Current Stimulation (tDCS)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02366611
NCT02366611N/ACompleted
CompareCT.gov

Pain Control Using Neuromodulation in Patients Undergoing Definitive Chemoradiotherapy for Locally Advanced Head and Neck Cancer

University of Michigan·interventional·Posted Feb 19, 2015·Updated Jan 22, 2021

In Brief

A clinical study evaluating Transcranial Direct Current Stimulation (tDCS) for Cancer of Head and Neck. Completed, enrolled 11 participants across 1 site.

Detailed Summary

The purpose of this study is to determine if Transcranial Direct Current Stimulation (tDCS) can reduce pain perception associated with the effects of receiving definitive radiation therapy or chemoradiotherapy in head and neck cancer (HNCa) patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCancer of Head and Neck
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedFeb 19, 2015
Enrollment StartNov 1, 2014
Primary CompletionNov 1, 2019
TodayJul 2, 2026
Enrollment to primary: 5 yearsPosted 11.4 years ago

Interventions

Transcranial Direct Current Stimulation (tDCS)device

tDCS is a non-invasive brain neuromodulatory method that involves sending a weak electrical current to the brain. 2mA of tDCS will be applied for 20 minutes at each session and participants will undergo a total of 20 sessions over a 7-week period.